Literature DB >> 12963770

Psychiatric adverse events during levetiracetam therapy.

M Mula1, M R Trimble, A Yuen, R S N Liu, J W A S Sander.   

Abstract

The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three (10.1%) patients developed PAE. A significant association was found with previous psychiatric history, history of febrile convulsions, and history of status epilepticus, whereas lamotrigine co-therapy had a protective effect. PAE were not related to the titration schedule of LEV, and certain patients seem to be biologically more vulnerable.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12963770     DOI： 10.1212/01.wnl.0000078031.32904.0d

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  48 in total

Review 1.  New drugs for the treatment of epilepsy: a practical approach.

Authors:  S Beyenburg; J Bauer; M Reuber
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

2.  Clear indications of emotion depend on vivid stimuli.

Authors:  J Zihl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 3.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 4.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Considering iatrogenic psychosis after malignant glioma resection.

Authors:  Ashish Harish Shah; Catherine E Gordon; Amade Bregy; Nirav Shah; Ricardo Jorge Komotar
Journal:  BMJ Case Rep       Date:  2014-04-23

Review 6.  Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

7.  Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.

Authors:  Vincenzo Belcastro; Laura Rosa Pisani; Silvio Bellocchi; Paolo Casiraghi; Gaetano Gorgone; Marco Mula; Francesco Pisani
Journal:  J Neurol       Date:  2017-03-18       Impact factor: 4.849

8.  Levetiracetam-induced acute psychotic episode.

Authors:  Srinivas Dannaram; Dileep Borra; Madhuri Pulluri; Prachi Jindal; Ashish Sharma
Journal:  Innov Clin Neurosci       Date:  2012-10

9.  Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures.

Authors:  Carol M Ulloa; Allen Towfigh; Joseph Safdieh
Journal:  Neuropsychiatr Dis Treat       Date:  2009-09-15       Impact factor: 2.570

10.  Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system.

Authors:  Anne C VanCott; Joyce A Cramer; Laurel A Copeland; John E Zeber; Michael A Steinman; Jeffrey J Dersh; Mark E Glickman; Eric M Mortensen; Megan E Amuan; Mary Jo Pugh
Journal:  BMC Med       Date:  2010-01-11       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.